Stephen Ray Mitchell's most recent trade in Vanda Pharmaceuticals Inc was a trade of 7,000 Common Stock done at an average price of $4.6 . Disclosure was reported to the exchange on June 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 4.59 per share. | 13 Jun 2025 | 7,000 | 97,082 (0%) | 0% | 4.6 | 32,130 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 59,225 | 104,082 (0%) | 0% | 0 | Common Stock | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 5.17 per share. | 14 Nov 2024 | 5,000 | 44,857 (0%) | 0% | 5.2 | 25,863 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 37,578 | 37,578 | - | - | Stock Option (right to buy) | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 20,529 | 49,857 (0%) | 0% | 0 | Common Stock | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 6.05 per share. | 10 Aug 2023 | 6,500 | 29,328 (0%) | 0% | 6.1 | 39,349 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (right to buy) | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 35,828 (0%) | 0% | 0 | Common Stock | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 24,707 | 24,707 | - | - | Stock Option (right to buy) | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,006 | 18,521 (0%) | 0% | 0 | Common Stock | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 9.48 per share. | 13 Jun 2022 | 2,700 | 6,515 (0%) | 0% | 9.5 | 25,593 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 16.74 per share. | 09 Sep 2021 | 19,109 | 9,215 (0%) | 0% | 16.7 | 319,976 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 09 Sep 2021 | 13,124 | 28,324 (0%) | 0% | 12.7 | 166,675 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 13,124 | 21,876 | - | - | Stock Option (right to buy) | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 5,985 | 0 | - | - | Stock Option (right to buy) | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.57 per share. | 09 Sep 2021 | 5,985 | 15,200 (0%) | 0% | 10.6 | 63,261 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 19.42 per share. | 15 Jun 2021 | 5,000 | 9,215 (0%) | 0% | 19.4 | 97,122 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 4,015 | 5,985 | - | - | Stock Option (right to buy) | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.57 per share. | 15 Jun 2021 | 4,015 | 14,215 (0%) | 0% | 10.6 | 42,439 | Common Stock |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Vanda Pharmaceuticals Inc | Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 10,200 (0%) | 0% | 0 | Common Stock |